If you still associate Johnson & Johnson brands with Band-Aid, Johnson’s Baby, and Tylenol, you’re a little out of date. After a major restructuring and the spin-off of its consumer-health arm into Kenvue in 2023, Johnson & Johnson today is a focused healthcare company built around pharmaceuticals and medical devices.
This guide explains what Johnson & Johnson does now, how its business is structured and which Johnson & Johnson products remain inside the company. We answer who really owns famous names like Tylenol — without confusing J&J with its former consumer brands.
What Does Johnson & Johnson Do Today?
As of 2025, Johnson & Johnson operates in two core segments: Innovative Medicine (its prescription drug business) and MedTech (its medical devices and technologies division). Together, these units focus on therapies and technologies for serious diseases rather than everyday consumer products.
Innovative Medicine develops and markets prescription treatments in areas such as oncology, immunology, neuroscience, cardiopulmonary disease, and specialty ophthalmology. MedTech, under the Johnson & Johnson MedTech banner, provides solutions for surgery, orthopedics, cardiovascular care, and vision — the kinds of tools hospitals rely on for complex procedures.
For a broader look at how pharma is evolving around these areas, see Industry Tap’s overview of pharmaceutical trends shaping healthcare.
What Brands Does Johnson & Johnson Own Now?
In August 2023, Johnson & Johnson completed the separation of Kenvue, its former consumer-health division. Kenvue became a fully independent, publicly traded company, and J&J exited control of its legacy consumer brands.
According to Johnson & Johnson’s own consumer-products page, Tylenol, Band-Aid Brand, Johnson’s Baby, Neutrogena, Aveeno, Listerine and similar names now belong to Kenvue Inc., not Johnson & Johnson. Those are often still searched as “Johnson and Johnson brands,” but they now sit outside the J&J corporate perimeter.
Today, when you’re talking about Johnson & Johnson brands inside the company, you’re mostly talking about:
- Johnson & Johnson Innovative Medicine – a portfolio of advanced prescription therapies across cancer, immune diseases, and neurological conditions.
- Johnson & Johnson MedTech – medical technology platforms for surgery, orthopedics, cardiovascular and vision care. Many of these used to be marketed under names like Ethicon, DePuy Synthes, Biosense Webster, Abiomed, and CERENOVUS.
If you’re interested in the manufacturing side of this, Industry Tap’s piece on why precision matters in modern medicine looks into how critical tolerances are for devices like implants and surgical tools.
What Companies Does Johnson & Johnson Own?
Johnson & Johnson is a parent company that operates through major business units and subsidiaries rather than a loose collection of unrelated companies. The two main pillars are its Innovative Medicine business and its MedTech division, with several well-known brands sitting under those umbrellas.
| Level | Business unit / brand | What it does |
|---|---|---|
| Core business unit | Johnson & Johnson Innovative Medicine | Rebranded pharma business (evolved from the former Janssen group of companies) focused on prescription drugs for serious diseases. |
| Core business unit | Johnson & Johnson MedTech | Unified medtech division that brings multiple device and technology companies under one umbrella. |
| Key brand within J&J MedTech | Ethicon | Surgical technologies and suturing systems. |
| Key brand within J&J MedTech | DePuy Synthes | Orthopedics, joint reconstruction, trauma, and spinal products. |
| Key brands within J&J MedTech | Biosense Webster, Abiomed, CERENOVUS | Brands focused on electrophysiology, cardiovascular support, and neurovascular care, respectively. |
Johnson & Johnson has also announced plans to spin off its orthopedics business (DePuy Synthes) into a separate company within roughly the next two years, as part of a strategy to sharpen its focus on higher-growth areas.
For the official view of how these pieces fit together, J&J’s own site lays out its business segments, strategy, and portfolio.
Who Owns Johnson & Johnson and Where Is It Headquartered?
Who owns Johnson & Johnson?
Johnson & Johnson is a public company listed on the New York Stock Exchange under the ticker JNJ. Its ownership is spread across institutional investors, funds, and individual shareholders — no single person or family “owns” the company outright.
Where is Johnson & Johnson company headquarters?
J&J’s world headquarters are at 1 Johnson & Johnson Plaza in New Brunswick, New Jersey, USA, a site the company has highlighted as the hub of its innovation footprint in the state.
Who Owns the Tylenol Brand?
Tylenol is one of the most searched “Johnson and Johnson products”, but the ownership story has changed.
Today, Tylenol is a consumer health brand owned by Kenvue Inc. The company was spun out of Johnson & Johnson’s consumer-health division, and became fully independent in 2023.
In late 2025, Kimberly-Clark — best known for Kleenex and Huggies — announced a $48.7 billion deal to acquire Kenvue. This would place Tylenol, Band-Aid, Listerine, Neutrogena and other former J&J brands under the same corporate roof as Kleenex and Cottonelle. The transaction is still pending regulatory and shareholder approval and is expected to close in the second half of 2026.
So the short answer is:
- Johnson & Johnson no longer owns Tylenol.
- Kenvue currently owns Tylenol, with Kimberly-Clark lined up as its future parent if the acquisition closes as planned.
Johnson & Johnson Brands: Key Takeaways
To wrap it up, Johnson & Johnson brands are no longer the same thing as “brands you see on the drugstore shelf.” Inside the company, the focus is squarely on innovative medicines and medtech platforms. On the other side, everyday consumer names like Tylenol, Band-Aid and Neutrogena live in Kenvue — and potentially soon under Kimberly-Clark.
For readers comparing Johnson & Johnson products to the broader healthcare and manufacturing landscape, that distinction matters. J&J is now a concentrated pharma and medtech player, while its former consumer brands form a separate, fast changing consumer-health empire of their own.
To keep up with similar shifts in pharma, medtech and advanced manufacturing, keep an eye on Industry Tap’s ongoing coverage of corporate strategy, M&A and the tools behind modern healthcare.
